NCT07651592

Brief Summary

This randomized controlled trial aims to compare the effects of maternal voice, touch, and scent on pain and stress levels in newborns during a routine heel lance procedure. Newborns will be randomly assigned to one of three intervention groups or a control group. Pain and stress responses will be assessed using validated neonatal pain and physiological measures. The findings of this study may help identify effective, low-cost, and non-pharmacological interventions that can be used to reduce pain and stress in newborns during routine clinical procedures.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
3mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Jul 2026Oct 2026

First Submitted

Initial submission to the registry

June 11, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 16, 2026

Completed
15 days until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2026

Last Updated

June 16, 2026

Status Verified

June 1, 2026

Enrollment Period

2 months

First QC Date

June 11, 2026

Last Update Submit

June 11, 2026

Conditions

Keywords

NewbornMaternalVoiceTouchScentHeel Lancepain

Outcome Measures

Primary Outcomes (1)

  • Neonatal Infant Pain Scale

    The Neonatal Infant Pain Scale (NIPS), originally developed by Lawrence et al. (1993), was adapted into Turkish by Akdovan (Akdovan \& Yıldırım, 1999). NIPS is used to assess procedure-related pain in newborn infants. The scale evaluates five behavioral indicators-facial expression, crying, arm movements, leg movements, and state of arousal-as well as one physiological parameter, breathing pattern. Pain is assessed based on the evaluation of these behavioral and physiological responses.

    Before the procedure, during the procedure, and immediately after the procedure

Secondary Outcomes (1)

  • Newborn stress scale

    Before the procedure, during the procedure, and immediately after the procedure

Other Outcomes (2)

  • Newborn and Maternal Characteristics Form

    At baseline

  • Neonatal Physiological Parameters Monitoring Form

    Before the procedure, during the procedure, and immediately after the procedure

Study Arms (4)

Maternal Voice

EXPERIMENTAL

The recorded maternal voice will be presented to the newborn before, during, and after the procedure.

Other: Maternal Voice

Maternal Touch

EXPERIMENTAL

The mother will maintain contact with the newborn's palms before, during, and after the procedure to stimulate the grasp reflex and provide tactile sensory input.

Other: Maternal Touch

Maternal Scent

EXPERIMENTAL

The newborn will be exposed to maternal breast milk scent during the procedure.

Other: Maternal Scent

Control

NO INTERVENTION

Routine heel lance procedures will be performed, and no sensory intervention will be provided.

Interventions

The recorded maternal voice will be presented to the newborn before, during, and after the procedure.

Maternal Voice

The mother will maintain contact with the newborn's palms before, during, and after the procedure to stimulate the grasp reflex and provide tactile sensory input.

Maternal Touch

The newborn will be exposed to maternal breast milk scent during the procedure.

Maternal Scent

Eligibility Criteria

Age0 Days - 28 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Term newborns born between 37 and 42 weeks of gestation
  • Newborns without respiratory, cardiac, metabolic, neurological, or infectious diseases
  • Newborns not requiring oxygen therapy, phototherapy, or intravenous treatment
  • Newborns scheduled to undergo a routine heel lance procedure (metabolic screening or blood sampling)
  • Mothers willing to participate in the study
  • Written informed consent provided by the parent or legal guardian
  • Normal vital signs before the procedure (heart rate, respiratory rate, and oxygen saturation within normal limits)

You may not qualify if:

  • Preterm (\<37 weeks) or post-term (\>42 weeks) newborns
  • Presence of congenital anomalies or neurological disorders
  • Requirement for oxygen therapy, phototherapy, or intravenous treatment
  • Respiratory, cardiac, metabolic, neurological, or infectious disease
  • Abnormal vital signs before the procedure
  • Parent or legal guardian refusal to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kilis Alaeddin Yavaşça State Hospital

Kilis, 79000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Stress, PsychologicalPain

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Elif Simay KOÇ, Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome assessor responsible for evaluating pain and stress outcomes will be blinded to group allocation.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

June 11, 2026

First Posted

June 16, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

August 30, 2026

Study Completion (Estimated)

October 30, 2026

Last Updated

June 16, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations